EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Norcantharidin Ameliorates Experimental Ulcerative Colitis Through Epigenetic and Metabolic Reprogramming Involving IL-6/DNMT1/SOCS3 and AMPK/SIRT1/FOXO3a-Nrf2 Signaling

Eman H Yousef iD, Samia S Hawas, Mohamed M Salama iD, Mostafa E Metawee, Hader I Sakr iD, Sumaiah J Alarfaj iD, Amany A Alzokaky iD

International Journal of Molecular Sciences · 26.07.2026 · 27 (15) · 6666

DOI: 10.3390/ijms27156666 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 26.07.2026. Verfasst von Eman H Yousef und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Biochemistry (Biochemistry), Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Signal Transduction, Epigenesis, Genetic, Bridged Bicyclo Compounds, Heterocyclic. Die Arbeit nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Princess Nourah bint Abdulrahman University through the Researchers Supporting Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a chronic inflammatory disorder associated with cytokine imbalance, epigenetic alterations, and metabolic–redox dysfunction. Despite the widespread use of mesalazine (5-ASA), therapeutic limitations remain. Norcantharidin (NCTD), a synthetic cantharidin analogue, may provide multi-target protection against UC. Experimental colitis was induced in male Sprague-Dawley rats by intrarectal administration of 4% acetic acid (AA). Rats received oral NCTD (10 mg/kg), 5-ASA (100 mg/kg), or their combination for 8 days. Disease severity was assessed by disease activity index, body weight, colon length, colon weight/length ratio, and histopathology. Colonic biomarkers were evaluated using ELISA, qRT-PCR, Western blotting, and immunohistochemistry. Fe2+ and malondialdehyde (MDA) were measured as indicators of iron accumulation and lipid peroxidation. Molecular docking suggested that NCTD may adopt plausible binding poses within the binding pockets of AMPK, SIRT1, and DNMT1, providing structural support for potential protein–ligand interactions. NCTD significantly ameliorated AA-induced colitis, improving clinical and histological outcomes. These effects were associated with reduced IL-6, TNF-α, DNMT1, Fe2+, and MDA levels, restoration of SOCS3, activation of p-AMPK/SIRT1/FOXO3a signaling, and enhancement of Nrf2/HO-1 defenses. Combined NCTD/5-ASA treatment produced greater clinical and histological protection, with differential effects on molecular markers. Docking studies suggested favorable interactions of NCTD with AMPK, SIRT1, and DNMT1. NCTD treatment was associated with protection against experimental colitis, linked to modulation of inflammatory, epigenetic, metabolic, and antioxidant pathways.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativeSignal TransductionEpigenesis, GeneticBridged Bicyclo Compounds, HeterocyclicAnimalsMaleNF-E2-Related Factor 2Interleukin-6Sirtuin 1RatsRats, Sprague-DawleyAMP-Activated Protein KinasesForkhead Box Protein O3Suppressor of Cytokine Signaling 3 ProteinMolecular Docking SimulationDisease Models, Animal

Stichwörter der Autor:innen

5-aminosalicylic acidAMPKepigeneticmesalazinenorcantharidinulcerative colitis

Substanzen

NF-E2-Related Factor 2Interleukin-6Sirtuin 1AMP-Activated Protein KinasesBridged Bicyclo Compounds, HeterocyclicnorcantharidinNfe2l2 protein, ratForkhead Box Protein O3Suppressor of Cytokine Signaling 3 ProteinFOXO3 protein, rat

Autor:innen und Institutionen

  • Department of Pharmacology and Biochemistry (Biochemistry), Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Horus University-Egypt, New Damietta 34518, Egypt.
  • Department of Biochemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa 11152, Egypt.
  • Department of Histology, Faculty of medicine (Boys), Al-Azhar University, Cairo 11651, Egypt.
  • Department of Histology, General Medicine Practice Program, Batterjee Medical College, Jeddah 21442, Saudi Arabia.
  • Department of Medical Physiology, Faculty of Medicine, Cairo University, Cairo 12613, Egypt.

ORCID-Profile: Eman H Yousef, Mohamed M Salama, Hader I Sakr, Sumaiah J Alarfaj, Amany A Alzokaky

Förderung

  • Princess Nourah bint Abdulrahman University through the Researchers Supporting Project

Zitieren

APA

Yousef, E. H., Hawas, S. S., Salama, M. M., Metawee, M. E., Sakr, H. I., Alarfaj, S. J., & Alzokaky, A. A. (2026). Norcantharidin Ameliorates Experimental Ulcerative Colitis Through Epigenetic and Metabolic Reprogramming Involving IL-6/DNMT1/SOCS3 and AMPK/SIRT1/FOXO3a-Nrf2 Signaling. International Journal of Molecular Sciences, 27(15), 6666. https://doi.org/10.3390/ijms27156666

Vancouver

Yousef EH, Hawas SS, Salama MM, Metawee ME, Sakr HI, Alarfaj SJ, et al. Norcantharidin Ameliorates Experimental Ulcerative Colitis Through Epigenetic and Metabolic Reprogramming Involving IL-6/DNMT1/SOCS3 and AMPK/SIRT1/FOXO3a-Nrf2 Signaling. International Journal of Molecular Sciences. 2026;27(15):6666. doi:10.3390/ijms27156666

BibTeX
@article{Yousef2026,
  author = {Yousef, Eman H and Hawas, Samia S and Salama, Mohamed M and Metawee, Mostafa E and Sakr, Hader I and Alarfaj, Sumaiah J and Alzokaky, Amany A},
  title = {Norcantharidin Ameliorates Experimental Ulcerative Colitis Through Epigenetic and Metabolic Reprogramming Involving IL-6/DNMT1/SOCS3 and AMPK/SIRT1/FOXO3a-Nrf2 Signaling},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6666},
  doi = {10.3390/ijms27156666}
}
Kostenlos starten →